Telemedicine Adoption is on the Rise

Telemedicine Adoption is on the Rise

The rate of change across today’s clinical research landscape is breathtaking, especially for an industry that has historically been considered slow to adopt. As we face a world-wide pandemic the likes of which we’ve never seen before, our industry plays a critical...
Adapting Clinical Trial Protocol in Response to COVID-19

Adapting Clinical Trial Protocol in Response to COVID-19

Based on recent SCRS survey data, a vast majority of research sites (58%) anticipate that COVID-19 will negatively affect their clinical trial enrollment and nearly half of respondents (47%) feel COVID-19 will have a negative effect on retention. With the number of...
Hybrid DCTs Reduce Dropout Rates in Long-Term Studies

Hybrid DCTs Reduce Dropout Rates in Long-Term Studies

Clinical studies are carefully designed to address the unique needs of not only the sponsor, but more importantly, the patients that commit to participate. Depending on the nature and severity of the condition, study lengths vary. A cardiovascular outcome trial...
Telemedicine in the Era of Coronavirus Disease

Telemedicine in the Era of Coronavirus Disease

The Coronavirus Disease 2019 (COVID-19) is wreaking havoc around the globe. With a seemingly imminent pandemic on the horizon, healthcare organizations are rushing to prepare for the fallout. The Centers for Disease Control and Prevention warned that it expects the...